BP
SAGE

Ballentine Partners’s Sage Therapeutics SAGE Stock Holding History

Ballentine Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,360
Closed -$310K – 436
2017
Q1 		$310K Hold
4,360
– – 0.02% 171
2016
Q4 		$223K Buy
+4,360
New +$223K 0.02% 168